InnovaDerma PLC Director/PDMR Shareholding (2004V)
November 29 2019 - 8:26AM
UK Regulatory
TIDMIDP
RNS Number : 2004V
InnovaDerma PLC
29 November 2019
LEI: 213800WRAP6W8VDL6B38
InnovaDerma PLC
("InnovaDerma" or the "Company")
Director/PDMR shareholding
InnovaDerma (LSE: IDP), a UK developer of life sciences, beauty
and personal care products, announces that it was notified today,
that Joseph Bayer, Executive Chairman of the Company, has purchased
3,000 Ordinary Shares of EUR0.10 each in the Company at a price of
62.00 pence per Ordinary Share (the "Acquisition") which will be
held via his Australian Superannuation Fund which Mr Bayer
controls. He now holds 129,000 Ordinary Shares in the Company via
his Australian Superannuation Fund.
Following the Acquisition, Joseph Bayer has, through direct and
indirect holdings, a total interest in the Company of 161,840
Ordinary Shares representing approximately 1.12% of the issued
share capital of the Company.
This announcement contains inside information for the purposes
of Article 7 of EU Regulation 596/2014.
Further enquiries
InnovaDerma
Joe Bayer +61 (0)3 9863 8030
Kieran Callan c/o TB Cardew +44 (0)20 7930 0777
finnCap Ltd
Geoff Nash/ Kate Bannatyne +44 (0)207 220 0500
Alice Lane/Manasa Patil - Corporate www.finncap.com
Broking
---------------------------
TB Cardew
Shan Shan Willenbrock/Tom Allison + 44 (0)20 7930 0777
Olivia Rosser innovaDerma@tbcardew.com
---------------------------
1. Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Joseph Bayer
------------------------------- -----------------------------------
2. Reason for the Notification
--------------------------------------------------------------------
a) Position/status Executive Chairman
------------------------------- -----------------------------------
b) Initial notification/Amendment Initial notification
------------------------------- -----------------------------------
3. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
--------------------------------------------------------------------
a) Name InnovaDerma PLC
------------------------------- -----------------------------------
b) LEI 213800WRAP6W8VDL6B38
------------------------------- -----------------------------------
4. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of
transaction; (iii) each date; and (iv) each place where
transactions have been conducted
--------------------------------------------------------------------
a) Description of the EUR0.10 each ("Ordinary Shares")
Financial instrument,
type of instrument
Identification code IDP GB00BT9PTW34
------------------------------- -----------------------------------
b) Nature of the transaction Purchase of Ordinary Shares
------------------------------- -----------------------------------
c) Price(s) and volume(s) Volume and Price -3,000 Ordinary
Shares at 62 pence per share
------------------------------- -----------------------------------
d) Aggregated information:
Aggregated volume See 4c) above
Price
------------------------------- -----------------------------------
e) Date of the transaction 29 November 2019
------------------------------- -----------------------------------
f) Place of the transaction London Stock Exchange, Main Market
------------------------------- -----------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHUKUSRKOAAUAA
(END) Dow Jones Newswires
November 29, 2019 09:26 ET (14:26 GMT)
Innovaderma (LSE:IDP)
Historical Stock Chart
From Apr 2024 to May 2024
Innovaderma (LSE:IDP)
Historical Stock Chart
From May 2023 to May 2024